积极学习用于预测SARS-CoV-2的急性后遗症患者的严重程度
Jing Wang1, Amar Sra2, Jeremy C Weiss1
1National Library of Medicine, Bethesda, MD.
ArXiv
|July 30, 2025
概括
这项研究引入了一种新型的积极注意网络,用于预测SARS-CoV-2 (PASC) 患者的临床风险和识别SARS-CoV-2 (PASC) 患者的急性后续病例的进展事件. 该模型利用大型语言模型和主动学习来改善患者护理.
科学领域:
- 医疗信息学 医疗信息学
- 医疗保健中的人工智能
- 传染性疾病 传染性疾病
背景情况:
- 在全球范围内,SARS-CoV-2 (PASC) 后急性连续症对健康构成长期挑战.
- 识别诸如住院和再感染等进展事件对于管理PASC患者至关重要.
- 由于数据限制,现有的模型在PASC复杂的进展模式中扎.
研究的目的:
- 开发和评估一个积极关注网络,用于预测PASC患者的临床风险.
- 用文本时间序列特征和临床风险预测来识别PASC进展事件.
- 通过积极学习,提高临床风险预测和进展事件识别的准确性.
主要方法:
- 利用了第一个公开可用的18名PASC患者队列.
- 雇佣的大型语言模型Llama-3.1-70B-教导文本时间序列特征提取.
- 开发了一个积极关注网络,整合了临床专业知识和积极学习.
主要成果:
- 积极关注网络显示了预测PASC患者临床风险的潜力.
- 该模型有助于识别与临床风险相关的进展事件.
- 积极学习的整合旨在减少对增强预测的注释要求.
结论:
- 拟议的积极注意网络为PASC进展事件的识别提供了一个有希望的方法.
- 这种方法有可能改善SARS-CoV-2幸存者的患者护理和临床决策.
- 未来的研究可以扩大队列,并为更广泛的临床应用改进模型.
相关概念视频
Acute Respiratory Failure-II
368
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
368
Acute Respiratory Failure-I
334
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
334
Acute Respiratory Failure-V
209
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
209
Pneumonia III: Complications and Assessment
442
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
442
Acute Respiratory Failure-III
325
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
325
Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K


